WHAT MIGHT be called the "antibiotic era" of syphilotherapy began with the introduction of penicillin in the treatment of syphilis. Naturally, therefore, antibiotics developed since the introduction of penicillin also have been examined for their possible value in the treatment of syphilis. The new antibiotic aureomycin appears to have a wide range of antibacterial activity. The present report is concerned with an expansion of our previously reported investigations on its oral use in the treatment of syphilis.
It was evident from the report by Heilman1 that aureomycin possesses antispirochetal activity which is greater than that of penicillin against experimental infectious relapsing fever and leptospirosis icterohaemorrhagica. His observations led us to administer aureomycin orally to patients with early infectious syphilis2 and to patients with late cutaneous syphilis and neurosyphilis3. The results obtained showed that aureomycin has definite antisyphilitic activity when administered by
KIERLAND RR, HERRELL WE, O'LEARY PA. TREATMENT OF SYPHILIS WITH AUREOMYCIN ADMINISTERED BY MOUTH. Arch Derm Syphilol. 1950;61(2):185–195. doi:10.1001/archderm.1950.01530090015003
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: